Mangosteen fruit compound shows promise fighting cervical cancer cells
Medicinal Plants
The purple-rinded tropical fruit sold in Asian grocery stores contains a compound researchers are studying as a potential natural add-on to cancer therapy.
Mangosteen, a tropical fruit with a thick purple rind, contains a natural compound called alpha-mangostin. Researchers looked at how this compound acts on cervical cancer cells at the molecular level and found it may help slow tumor growth when used alongside standard treatments. It's still early lab-stage research, not a cure, but it points to a promising direction for combining plant compounds with modern medicine.
Key Findings
1
Alpha-mangostin is a xanthone compound extracted from the rind of the mangosteen fruit (Garcinia mangostana)
2
The compound appears to interfere with molecular pathways involved in cervical cancer cell survival and proliferation
3
Researchers propose it as a potential adjuvant (add-on) therapy to enhance existing cervical cancer treatments
chevron_right
Technical Summary
Scientists reviewed how a compound found in mangosteen fruit rind, alpha-mangostin, interferes with the growth of cervical cancer cells, suggesting it could one day support existing cancer treatments.
Mangosteen, also called mangostan or purple mangosteen, is a tropical evergreen tree with edible fruit native to the Malay Peninsula and Borneo. It has been cultivated extensively in tropical Asia since ancient times. It is grown mainly in Southeast Asia, southwest India and other tropical areas ...
